Copyright
©The Author(s) 2019.
World J Gastroenterol. Apr 21, 2019; 25(15): 1865-1878
Published online Apr 21, 2019. doi: 10.3748/wjg.v25.i15.1865
Published online Apr 21, 2019. doi: 10.3748/wjg.v25.i15.1865
Figure 2 UCB inactivated digestive protease activity in DSS treated mice.
A: Trypsin activity in feces; B: Chymotrypsin activity in feces. Data are expressed as means ± SEM (n = 5). cP < 0.001 vs control group and eP < 0.01 vs dextran sodium sulfate group. UCB: Unconjugated bilirubin; DSS: Dextran sodium sulfate; SEM: Standard error of the mean.
- Citation: Zheng JD, He Y, Yu HY, Liu YL, Ge YX, Li XT, Li X, Wang Y, Guo MR, Qu YL, Qin XF, Jiang MS, Wang XH. Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation. World J Gastroenterol 2019; 25(15): 1865-1878
- URL: https://www.wjgnet.com/1007-9327/full/v25/i15/1865.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i15.1865